GlassScriptPhysician profile
Charles Hua
NPI 1881014694
$1,935.64
in general payments reported to CMS, 2019-2025
11 companies · $82.64 in 2025
The $82.64 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $360 · 2021: $23.31 · 2022: $228 · 2023: $242 · 2024: $786 · 2025: $82.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $760 · Consulting Fee: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $760.04 |
| Consulting Fee | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $634.65 | 2020-2025 | Navicross, Azur Cx Detachable |
| Boston Scientific Corporation | $579.25 | 2019-2024 | Embold Fibered |
| Cardiva Medical, INC. | $187.10 | 2020-2022 | |
| Sirtex Medical INC | $148.92 | 2023 | Sir-Spheres Microspheres |
| Cook Medical LLC | $84.41 | 2021-2023 | Zilver Vena |
| Angiodynamics, INC. | $77.08 | 2022-2023 | Alphavac |
| Mediview Xr, INC. | $65.02 | 2025 | |
| Cardinal Health 200 LLC | $62.53 | 2020 | |
| Siemens Medical Solutions USA, INC. | $51.46 | 2022 | |
| Instylla, INC. | $27.48 | 2022 | |
| Ge Healthcare | $17.74 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Hua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.